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a  b  s  t  r  a  c  t
Neuromotor  processes  are  inherently  noisy,  which  results  in variability  during  movement  and  ﬂuctu-
ations  in  motor  control.  Although  controversial,  low  levels  of  variability  are  traditionally  considered
healthy,  while  increased  levels  are  thought  to be  pathological.  This  systematic  review  and  meta-analysis
of  the  literature  investigates  the  thresholds  between  healthy  and  pathological  task  variability.
After  examining  13,195  publications,  109 studies  were  included.  Results  from  over  3000  healthy  sub-
jects  and  2775  patients  revealed  an  overall  positive  effect  size  of pathology  on  variability  of  0.59  for
walking  and  0.80  for sway.  For  the  coefﬁcient  of  variation  of  stride  time  (ST)  and  sway  area  (SA),  upper
thresholds  of 2.6%  and  265  mm2 discriminated  pathological  from  asymptomatic  performance,  while 1.1%
and  62  mm2 identiﬁed  the  lower  thresholds  for  pathological  variability.  This  window  of  healthy  perfor-
mance  now  provides  science  based  evidence  for  the  discrimination  of  both  extremely  low  and  extremely
high  levels  of variability  in  the  identiﬁcation  as  well  as  standardised  monitoring  of functional  status  in
neurological  cases.
©  2016  The  Authors.  Published  by  Elsevier  Ltd.  This  is  an  open  access  article  under the  CC  BY license
(http://creativecommons.org/licenses/by/4.0/).
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1. Introduction
The effective performance of daily activities is based on rela-
tively simple movements such as standing or walking. However,
these tasks require complex control mechanisms within the human
∗ Corresponding author at: ETH Zürich, Institute for Biomechanics, HCP H21.2,
Leopold-Ruzicka-Weg 4, 8093 Zürich, Switzerland.
E-mail address: taylorb@ethz.ch (W.R. Taylor).
1 These authors provided equal contribution to this manuscript.
sensory motor system (HSMS) that provide timing, coordina-
tion and balance, and which deteriorate after the 6th decade of
life (Aagaard et al., 2010). This decline in neuromotor control is
reﬂected in an increased likelihood to fall (Prudham and Evans,
1981; Tinetti et al., 1988; Wickham et al., 1989) and suffer asso-
ciated injuries (Nutt et al., 2011; O’Loughlin et al., 1993), and is
even more accentuated in a variety of neurological disorders such
as Parkinson’s disease, dystonia, and dementia (Malatesta et al.,
2003). An improved understanding of the interactions between the
functioning of the HSMS and fundamental neuromotor ability is
therefore critical to foster healthy aging and independent living.
http://dx.doi.org/10.1016/j.neubiorev.2016.03.035
0149-7634/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Although subjective and simple observational measures such
as gait speed and posture can provide easy-to-use and relevant
tests for the evaluation of neuromotor status in clinical settings, the
monitoring of more subtle cases of functional degeneration, includ-
ing the early identiﬁcation of HSMS pathology and assessment of
treatment efﬁcacy, clearly require increasingly sensitive metrics.
Here, a growing body of evidence now indicates that the variability
of movement patterns, including postural sway and gait variabil-
ity, is capable of reﬂecting not only the status of the HSMS, but also
the overall quality of motor function (Hausdorff, 2009; Lord et al.,
2011). In postural sway, variability describes the non-constant or
ﬂuctuating behaviour of the centre of body mass about a target
point. During gait, variability describes the variation in movement
patterns between repetitive cycles (Stergiou et al., 2006). Indeed,
variability is an integral characteristic of any motor task (Bartlett
et al., 2007). In general, movement arises from the integration of
a multitude of central and peripheral neuromuscular systems to
receive, process, and transmit information in order to plan and
execute suitable actions (Frenkel-Toledo et al., 2005; Dietz, 1992;
Kurz et al., 2012; Dietz, 2003; Ivanenko et al., 2009). However,
each of these neuromotor processes, including sensory perception,
cortical processing, neural signalling, and motor-neuron ﬁring, is
inherently noisy (Faisal et al., 2008) which is thought to result in
variability during movement patterns and ﬂuctuations in motor
control. Concomitantly, an increase in motor variability has been
observed through ageing and neuromotor pathologies (Hamacher
et al., 2011; Hausdorff et al., 1998). Together, these observations
have driven the consensus of proportionality between variability
and task performance, leading to the traditional perspective that
low levels of variability are healthy, while increased levels of vari-
ability reﬂect degenerated performance and malfunctioning of the
HSMS.
Contrary to these clinical opinions, recent evidence suggests
that variability is not entirely the result of noisy information, and is
not necessarily disadvantageous. In this context, deterministic pro-
cesses have been identiﬁed within movement variability that are
distinguishable from random noise (Russell and Haworth, 2014;
Dingwell and Cusumano, 2000; Dingwell and Kang, 2007; Huisinga
Jessie et al., 2012; Roerdink et al., 2006), thereby indicating that
control mechanisms within the HSMS are able to partially govern
movement variability (Dingwell and Cusumano, 2000; Dingwell
and Kang, 2007). Furthermore, it has been shown that movement
variability can be adapted ﬂexibly by subjects depending on the
goal of a motor task (Wilson et al., 2008; Pekny et al., 2015; Wu
et al., 2014) (consider the case of a trained darts or snooker player)
or during motor learning (Harbourne and Stergiou, 2003). This evi-
dence has cast sufﬁcient doubt on the consensus of proportionality
between variability and task performance that a hypothesis of opti-
mal  levels of variability has been proposed. Unlike the traditional
linear association, it seems reasonable that a “U” shaped associ-
ation characterises the relationship between motor performance
and variability (Stergiou et al., 2006). Here, extremely high lev-
els of variability as well as excessively low levels of variability are
considered disadvantageous for motor performance. From a theo-
retical standpoint, the optimal feedback control theory claims that
the HSMS not only considers the successful execution of a motor
task (i.e. less variability reﬂects improved function), but also takes
into account the high energy cost required for neuromotor con-
trol (Todorov and Jordan, 2002). On a practical level, the additional
supra-spinal inputs might explain why subjects carefully placing
a coffee pot on the table exhibited higher internal musculoskele-
tal forces (reﬂecting higher levels of energy expenditure) than was
required to lift it again (lower level of control) (Westerhoff et al.,
2009). Thus, movement tasks are likely to be executed at an opti-
mum  between sufﬁcient accuracy and minimal control costs, which
poses the question of whether an optimal window of variability
exists while undertaking normal activities of daily living such as
walking and standing. A more comprehensive understanding of
movement variability could therefore establish the subtle aspects
of movement “error” as a functional biomarker for the early identi-
ﬁcation of pathology or for monitoring disease progression, as well
as for evaluating therapy efﬁcacy in different patient groups.
The biggest hurdle for uptake of movement variability as a
biomarker in clinical settings is the lack of clear deﬁnitions for
optimum task performance. Considering the lifetime spent in per-
forming and mastering walking and standing, it is plausible that
healthy subjects perform these every-day tasks within an opti-
mal  window of variability. Since strong evidence indicates that
subjects with a malfunctioning HSMS (i.e. neurological patients)
will perform at levels outside of this window, a systematic review
and meta-analysis of the copious literature assessing movement
variability, including clinical cohorts, should allow the boundaries
between normal physiological and pathological variability during
movement to be discovered.
2. Methods
2.1. Publication search and selection
Between May  and July 2014 a systematic literature review
was conducted with the aim to comprehensively identify stud-
ies in which measures of variability during standing or walking
were collected in both a cohort of healthy elderly and a cohort of
patients with a neurological pathology. In order to do so, a com-
mon  search string was entered into four different databases (Fig. 1).
The search string containing Boolean operators was  constructed so
that an AND-combination of terms speciﬁed the task (e.g. walk*),
measure (e.g. variability)  and cohort (e.g. Parkin*). Within these cate-
gories synonyms as well as speciﬁcations of additional pathological
cohorts were combined using the OR operator. Additionally a NOT-
condition was  applied to exclude studies involving e.g. animals,
genes, heart-rate etc. The search was additionally limited to original
research articles published after the year 1980. The complete search
string can be observed in the electronic supplementary material.
After removal of duplicates, the search revealed 13′195 publi-
cations potentially relevant for the study. Titles and abstracts were
screened by two  reviewers (NK & NS) independently and excluded
according to predeﬁned criteria that ensured appropriateness of the
studies to our research question. Disagreement between reviewers
was solved by consensus. After the ﬁrst screening, the complete
manuscripts of the remaining 633 publications were retrieved.
Here, 52 articles could not be acquired despite attempts to con-
tact the authors directly. Subsequently the methods section of
all articles was  screened by both reviewers independently and
studies were excluded in a similar process. Of the remaining 141
publications, relevant information on the task performed, mea-
surement technology, outcome parameters and cohort information
was extracted. During this process, a further 25 publications were
excluded (please see complete list of exclusions in the electronic
supplementary material) due to duplication of the data (multiple
publications), incomplete data presentation or lack of methodolog-
ical details, resulting in a set of 109 studies that were included in
the meta-analysis.
2.2. Meta-analysis
The aim of the meta-analysis was  two-fold: ﬁrstly, to assess
the effect of malfunctioning of the HSMS on movement variabil-
ity, and secondly to determine threshold levels that deﬁne the
boundaries of healthy movement variability to pathology. In order
to achieve this, means and standard deviations (SD) of variabil-
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Fig. 1. PRISMA Flow diagram of publication screening and selection procedure.
*Note that one study presented results on both walking and standing.
ity measures for both asymptomatic and neuromotor pathological
cohorts were extracted. In cases where standard error of the mean
(SEM) or 95% conﬁdence intervals (95CI) were presented, these val-
ues were translated into SD as recommended by Cochrane. (Higgins
and Green, 2011) An effect size (ES) for each study was  then deter-
mined according to Cohen. (Cohen, 1988) In addition, each ES was
corrected for sample size according to Eq. (1), adjusted to provide
Hedges’ g denoted as ES’ (Lipsey and Wilson, 2001):
ES
′ = ES
[
1 − 3
4N − 9
]
(1)
Finally, in order to assess the effect of a malfunctioning HSMS on
variability during walking and standing, a mean ES’  over all studies
was calculated according to:
ES =
∑
(w × ES)∑
w
(2)
w = 1
se2
(3)
where w was a weighting factor determined using the standard
error of measure, se. Heterogeneity was assessed using Cochrane’s
Q and I2 statistics.
2.3. Statistical procedure for identiﬁcation of thresholds for
optimal variability
For each of the two tasks, walking and standing, a binary
logistic regression (BLR) analysis was performed on the most com-
monly reported measures in order to assess how these parameters
classify the two groups. The advantage of using BLR is that it
provides an underlying continuous distribution (logistic curve-ﬁt)
of the dichotomous response variable (0 for healthy and 1 for
pathological) in terms of the variability parameters. The logistic
curve-ﬁt was  ﬁrstly analysed using the Chi-square goodness-of-
ﬁt test, while the quality of the classiﬁcation was  evaluated using
a receiver-operating characteristic (ROC) procedure. For each of
the commonly reported measures we then identiﬁed the optimal
operating point, yfitoop with balanced levels of sensitivity as well as
speciﬁcity. This optimal yfitoop according to Eq. (4):
loge
(
yfitoop
1−yfitoop − b0
)
b1
= xoop (4)
was then used in an inverse binary logistic regression function in
order to assess the optimal threshold value xoop for each of the most
commonly reported measures.
3. Results
3.1. Gait variability
The systematic search retrieved 64 publications reporting mea-
sures of variability during walking. In total this data was based
on 1657 pathological (average mean age: 61.6 ± 15.2 years) and
1915 healthy control (average mean age: 59.7 ± 14.0 years) sub-
jects, of which the majority of studies assessed patients with
basal ganglia disorders (42 studies; 60%), comprising patients with
Parkinson’s or Huntington’s disease. Mostly, subjects walked at
self-selected speed over ground (56 studies; 81%) and gait patterns
were assessed using footswitches (19 studies; 27%) or pressure sen-
sitive carpets (18 studies; 26%). Approximately half of the studies
(52%) included 50 or more steps in their analysis, which is report-
edly required for reliable assessment of gait variability (Galna et al.,
2013; Konig et al., 2014). The parameter most commonly reported
was coefﬁcient of variation of stride time (ST; 38 studies; 55%;
Supplementary material; Table 1). The only parameters of gait to
exhibit reduced variability in pathological cases were variability of
step width (7 studies), and SD stance time (2 studies).
Within the 64 publications that were retrieved, multiple param-
eters as well as pathological groups were reported, resulting in a
total of 119 ES values, with an I2 value of 8.4%, and an average
Cochrane’s Q of 128.8. The forest plot (Fig. 2) reveals a positive effect
size of pathology on variability with an ES = 0.59. All patient groups,
except for the Brain Injury group showed a signiﬁcantly increased
variability during walking compared to the healthy group (p < 0.01;
Table 1).
The BLR based on the parameter ST included a total of 38 stud-
ies with 739 pathological and 814 asymptomatic participants and
revealed an area under the curve (AUC) of 0.8, a sensitivity of 0.8,
and a speciﬁcity of 0.7. In the inverse logistic regression the corre-
sponding optimal xoop value was 2.6 [2.3;3.1]% ST. Only few studies
reporting smaller values of ST for the pathological group were iden-
tiﬁed. Hence, the lower bound of physiological ST was  estimated as
the lowest observed group value for the asymptomatic subjects,
which was  1.1% ST.
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Table 1
Effect size statistics including the z-test and p-values across all patient groups for parameters of both gait variability and postural sway.
Basal Ganglia Including:
Parkinson’s disease,
Huntington’s disease
Brain Injury Including:
Stroke, Traumatic brain
injury
Cerebellar
Including:
Cerebellar ataxia,
Essential tremor,
Spinocerebellar
ataxia
Cognitive Including:
Alzheimer’s, Major
affective disorders, Mild
cognitive disorders,
William’s syndrome
Global Including: Multiple
sclerosis, ALS, Progressive
Supranuclear Palsy,
Binswanger disease
Peripheral Including:
Peripheral neuropathy
Overall
Gait parameters
Mean effect size 0.60 0.41 1.11 0.46 0.41 1.29 0.59
Mean  standard error 0.07 0.31 0.27 0.13 0.19 0.41 0.06
Number of comparisons 77 6 6 17 10 1 119
Cochrane’s Q 59.6 11.4 3.6 23.8 18.1 3.6 129.1 (120.1 8.9)a
Z-test 8.25 1.30 4.09 3.58 2.16 3.16 10.25
p-value <0.01 0.10 <0.01 <0.01 0.02 <0.01 <0.01
Sway  parameters
Mean effect size 0.63 0.81 1.16 2.21 0.87 0.99 0.80
Mean  standard error 0.11 0.12 0.37 0.40 0.27 0.40 0.07
Number of comparisons 34 25 5 3 6 3 77
Cochrane’s Q 48.7 18.3 19.9 11.3 0.9 7.0 121.7 (106.1 15.7)a
Z-test 5.73 6.58 3.12 5.47 3.22 2.50 10.80
p-Value <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01
a The values for between and within group homogeneity statistics are included.
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Fig. 2. Forest plot for gait parameters that presents the effect sizes for different neurological pathology groupings (see Table 1), but also the mean effect size of 0.59 based
on  1657 pathological and 1915 healthy subjects (shown as a yellow diamond). Analysis of these results indicates that a CV of stride time of 2.6% discriminates healthy from
pathological motor variability.
3.2. Postural sway
The systematic search for postural sway revealed 46 studies in
total. This included a total of 1118 pathological subjects (average
mean age: 59.4 ± 10.2 years) and 1086 healthy controls (average
mean age: 58.8 ± 12.1 years). The majority of patients belonged
to the basal ganglia (20 studies; 41%) or brain injury (16 studies;
33%) groups. Mostly, subjects were measured using force plates
(40 studies; 83%) in an erect posture with their eyes open (44
studies; 91%). The parameter most commonly reported was sway
area (SA; 26 studies; 54%; Supplementary Table 2). The majority
of studies (89%) included standing trials of 30 seconds or longer,
which has been deﬁned as a prerequisite for the reliable assess-
ment of sway (Pinsault and Vuillerme, 2009). All parameters of
sway were increased in pathological cases except for sway in the
anterior-posterior direction (1 study), and frequency of sway in the
anterior-posterior direction (1 study).
Similar to gait variability, multiple parameters as well as
pathological groups were reported, resulting in a total of 77 ES
comparisons, with an I2 value of 37.6%, and an average Cochrane’s
Q of 121.7. An overall positive effect of pathology on standing
sway became apparent with a signiﬁcant effect size of 0.8 (p < 0.01;
Table 1). All patient groups showed signiﬁcantly increased postural
sway compared to healthy subjects (p < 0.01).
BLR based on the parameter SA included 26 studies with 447
patients and 420 asymptomatic participants, and revealed an AUC
of 0.6, a sensitivity of 0.6, and a speciﬁcity of 0.7. Inverse regression
revealed the higher bound of physiological SA to be xoop =265.0
[149.7;480.0] mm2. The lowest reported sway area among asymp-
tomatic participants across all studies revealed the lower bound of
physiological SA as 66.7 mm2 (Fig. 3).
4. Discussion
Patients with neurological pathologies exhibit exaggerated
movement and control patterns, but the limits between physio-
logically normal and pathological variability during walking and
standing have remained elusive. This review and meta-analysis
of over 13′000 scientiﬁc articles now provides the highest level
of evidence to elucidate the relationship between functioning of
the HSMS and motor task performance, and was  therefore clearly
indicated. For the most commonly reported parameters of ST and
SA, an upper threshold level of 2.6% and 265.0 mm2 discrimi-
nates pathological from asymptomatic performance with an overall
accuracy of 80% and 60% for walking and standing respectively.
Only a low number of studies have reported decreased variabil-
ity for the pathological groups, restricting statistical conclusions.
Interestingly, all patient groups exhibited increased postural sway,
irrespective of whether they suffered from hypo- or hyperkinetic
movement disorders. The lowest measured ST and SA in an asymp-
tomatic cohort suggests that 1.1% and 62 mm2 are reasonable
boundaries for identifying pathological motor patterns. For the ﬁrst
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Fig. 3. Forest plot for sway parameters that presents the effect sizes for different neurological pathology groupings (see Table 1), and shows a mean effect size of 0.8 based
on  1118 pathological and 1086 healthy subjects (shown as a yellow diamond). Analysis of these results indicates that a sway area of 265.0 mm2 discriminates healthy from
pathological sway.
time, these boundaries for physiological vs. pathological perfor-
mance demonstrate the power of movement variability to serve as a
functional biomarker for the identiﬁcation of neuromotor patholo-
gies, as well as a target for treatment outcome or for the modulation
of therapy dosage in clinical practice.
Based on the presented data, it would appear that the current
meta-analysis not only represents the effect of pathology on
movement performance, but also the effect of disease sever-
ity. Further comparison of the clinical disease rating scales
and the associated ESs revealed that lesser affected patient
cohorts produced smaller ESs for stanceSM53, SM100, SM106 as
well as for gait, where the UPDRS motor subscale scores were
positively associated to ESs (Pearson correlation: r = 0.44;
p = 0.09)SM29, SM30, SM32, SM60, SM80, SM86, SM103, SM105, SM106&SM107.
Similarly, the stance of Parkinson’s patients measured in the ON
medication state (81% of studies; average ES = 0.6) produced a
smaller ES compared to those tested in the OFF state (average
ES = 1.0). However, no effect of the levodopa status was observed
in the gait dataset (72% of studies measured walking in the ON
condition). Here, average ESs for the two subgroups were similar
with 0.54 and 0.58 for both the ON and OFF states respectively. We
assume that this ﬁnding is due to biased patient selection, as stud-
ies measuring walking performance in the OFF condition might
include less severely affected patients in order to successfully
complete the measurement protocol.
As apparent from the almost consistent increase in variability
across all investigated patient cohorts, it can be concluded that any
disturbance within the HSMS leads to a more variable motor perfor-
mance. However, a detailed examination of the data suggests that
different parameters of gait and balance exhibit varying behaviour
with pathology. In the gait dataset, particularly within the Basal
ganglia group, it appears that stride time or stride length variabil-
ity results in large positive ESse.g.SM44, SM32. Conversely, negative
ESs were almost exclusively observed for measures of step-width
variabilitye.g.SM14, SM86, SM99. This observation might indicate that
progressive decline in lower extremity muscle tone and postu-
ral reﬂexes in Parkinson patients could lead to reduced levels of
variability of step width, primarily to maintain a stable centre of
mass in the medio-lateral direction (Rochester et al., 2014). This
result suggests that relaxing control of one dimension may allow
control of another to be tightened, or vice versa, thus selectively
heightening sensory feedback towards parameters that are criti-
cal for successful task performance (Todorov and Jordan, 2002). It
is therefore reasonable that due to the multidimensionality of vari-
ability, different pathologies of the HSMS exhibit speciﬁc and subtle
movement signatures or, alternatively, that movement signatures
are the result of compensation mechanisms that make success-
ful task performance possible, and that depend upon the disorder
(Lord et al., 2013). Similarly, it has been shown that the cerebel-
lar group shows largest ESs for measures that quantify consistency
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Fig. 4. Funnel plot for studies reporting on (A) gait task and (B) stance task.
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of forward progression (e.g. step length variability)SM33, SM35, SM92.
This result is in accordance with ﬁndings of Schniepp and col-
leagues who showed that spatio-temporal variability in patients
with cerebellar ataxia is markedly increased compared to values of
patients with Parkinson’s disease, as well as those with supranu-
clear palsy (Pradhan et al., 2015). It is therefore plausible that
the cerebellum plays a prominent role in controlling balance in
the anterior-posterior direction, whereas rhythmicity of movement
(represented by variability of stride time) is less affected in these
patientsSM92. The complex inter-dependency between the pathol-
ogy of different neurophysiological structures and parameters of
variability in the motor outcome therefore limits any clear inter-
pretation of the cause-effect relationships.
This review has highlighted the similarity in motor outcome
between subjects with a variety of neurological pathologies. How-
ever, to gain a full understanding of the inter-relationships between
the speciﬁc neural pathology and their motor function, multivariate
analyses that examine the subtle variations in movement signa-
tures, including e.g. combinations of temporal and spatial, as well
as non-linear measures of movement performance, are clearly indi-
cated. It remains unclear whether an optimal level of variability
for motor performance exists (Stergiou et al., 2006). From a tra-
ditional perspective, extremely high levels of variability have been
considered detrimental, and have been associated with unstable
task performance. However, extremely low levels of variability,
although still largely elusive in the scientiﬁc literature, might indi-
cate a functionally rigid system with only a limited capacity to
adjust to internal and external perturbations. Recent empirical
studies now suggest that subjects with a diminishing skill level
(e.g. a positive history of falling) have either lower or higher lev-
els of variability compared to their asymptomatic counterparts
(Singh et al., 2012; Brach et al., 2005). However, these single reports
have only provided limited evidence to support the hypothesis
of a “U-shaped” relationship between variability and functional
performance. In addition, a discussion on the appropriateness of
magnitude measures of variability to represent unstable and rigid
movement performance is clearly required. In addition, methods
that are able to characterise the structure of variability throughout a
time series may  well provide additional validity or sensitivity to the
analyses performed (Stergiou et al., 2006; Dingwell and Cusumano,
2000; Dingwell and Kang, 2007; Roerdink et al., 2006).
The logistic regression presented in this study of the literature
has only considered the CV of stride time and sway area as the
two most frequently reported gait and balance variables. Here, reli-
ability of the presented data needs to be critically evaluated. In
the case of studies that examined walking, only half fulﬁlled the
requirements for reliable data collection, where it is suggested that
at least 50 steps are necessary for the reliable assessment of gait
variability (Galna et al., 2013; Konig et al., 2014). Interestingly how-
ever, a comparison of ESs between studies that included more than
50 steps compared against those with fewer showed no signiﬁ-
cant differences. This surprising outcome is possibly the result of
the same low-reliability protocols being used to examine both the
pathological and the control cohorts, thus affecting both groups
equally.
Two possible limitations of this systematic review are likely
to inﬂuence our understanding of the inter-relationships between
motor variability and functional performance. Critically, publica-
tion bias, and the lack of reported unexpected or negative results,
is a general problem that is difﬁcult to overcome. It seems plausible
that observations contradicting the general consensus about a mal-
functioning HSMS resulting in increased levels of variability might
be considered false, with reduced chances of successful publication.
This potentially leads to overestimation of the mean ES found in the
meta-analysis. Indeed, the funnel plots of our data (Fig. 4) show
asymmetrical distribution towards positive ESs, which is indica-
tive of reduced likelihood of studies being published that report
negative or no ESs (i.e. a pathological cohort performs with lower
levels of variability). However, asymmetry in the funnel plots was
mainly caused by small studies with large standard errors. More
trustworthy studies with smaller standard errors were also mostly
equally distributed around the mean ES. As the mean ES was  cal-
culated based on each ES weighted by their standard error (Eqs. (2)
& (3)) the risk of ES overestimation in this meta-analysis was  min-
imised. In addition, most commonly applied statistical approaches
assume a linear relationship or a one-sided difference between
groups. However, under these conditions, a “U-shaped” association
would remain uncovered due to misleading averaging of the data,
resulting in inappropriate pooling into single datasets with high
variance. The outcome is that only few differences between groups
become apparent, possibly further increasing publication bias. Fur-
thermore, studies that average extremely high with extremely
low results would result in ESs close to zero, hence leading to
an underestimation of the boundaries between physiological and
pathological variability proposed here. In this respect, studies util-
ising more appropriate analyses that consider the position of each
case within the population examined, should allow recognition of
non-linear relationships between cohorts.
In this meta-analysis, it is important to consider the lack of
detailed information on speciﬁc cases and their diagnosis, which
might have led to inconsistent group allocation. For example, it is
possible that the “brain injury” group could have included subjects
with injuries to the basal ganglia. Unfortunately, as this informa-
tion could not be corroborated during the review process, it was
not possible to determine the uniformity of the allocations. How-
ever, it would appear that the choice of functional parameter (e.g.
variation of stride time vs. variation of step width) rather than
the underlying pathology is dominant in guiding the direction and
magnitude of the ESs. In a similar manner, heterogeneity between
publications is a crucial aspect in meta-analyses. For gait variabil-
ity, an I2 value of 8.4% was obtained, which represents excellent
consistency between studies. Although the studies that considered
sway revealed a higher I2 value of 37.6%, this is still within the rec-
ommended guidelines (Higgins and Green, 2011). Considering the
large variety in populations, study assessment techniques, proto-
cols, age of cohorts, sample sizes etc., I2 values of between 8.4% and
37.6% could still be considered very good.
In conclusion, despite possible inﬂuence of publication bias, the
data reviewed in this study suggest that any disturbance of the
HSMS is likely to result in an increase in movement variability.
Reduced levels of variability are only present for a few parame-
ters of walking and standing, and thus pose the question of the
neural aetiology in such cases. Based on the theoretical consider-
ation of excessively low levels of variability, we  therefore suggest
that individual performance comparisons be presented in addition
to group-based statistics. However, based on the results of over
3000 healthy subjects and 2775 patients, this meta-analysis indi-
cates that a CV of stride time between 1.1% and 2.6%, and a sway
area of between 67 mm2 and 265 mm2 indicate healthy neuromo-
tor function. These values can now be used in clinical settings for
identiﬁcation of subtle changes while monitoring motor perfor-
mance.
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